Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens

Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin

1993 • 724 citations

Treatment of Multidrug-Resistant Tuberculosis

1993 • 722 citations

Levofloxacin

1994 • 326 citations

Multidrug-Resistant Tuberculosis in Patients without HIV Infection

1995 • 216 citations

Renal hemodynamic effects of calcium antagonists

1987 • 168 citations

Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

1985 • 164 citations

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

1996 • 163 citations

Drug-resistant tuberculosis: laboratory issues

1994 • 158 citations

Improved Outcomes for Patients with Multidrug-Resistant Tuberculosis

1995 • 144 citations

Emergence of fluoroquinolone-resistant tuberculosis in New York City

1995 • 124 citations

Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

1998 • 111 citations

Predictors and Outcome of Multidrug-Resistant Tuberculosis

1995 • 102 citations

Retreatment Tuberculosis Cases

1997 • 99 citations

Ofloxacin

1991 • 93 citations

Selection of a gyrA Mutant of Mycobacterium tuberculosis Resistant to Fluoroquinolones during Treatment with Ofloxacin

1994 • 89 citations

In-vitro activity of quinolones and macrolides against mycobacteria

1994 • 87 citations

Randomized Controlled Trial of a Drug Regimen That Includes Ciproftoxacin for the Treatment of Pulmonary Tuberculosis

1996 • 86 citations

In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis

1990 • 84 citations

A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin

1992 • 72 citations

Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages

1994 • 67 citations

In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).

1985 • 61 citations

Prospective Comparative Study of Ofloxacin or Ethambutol for the Treatment of Pulmonary Tuberculosis

1992 • 60 citations

In-vitro susceptibility of mycobacteria to ciprofloxacin

1985 • 55 citations

Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections.

1995 • 48 citations

Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance

1997 • 47 citations

In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis

1987 • 45 citations

Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.

1999 • 33 citations

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria

1987 • 29 citations

Epidemiology, Control and Treatment of Multidrug-Resistant Tuberculosis

1996 • 26 citations

Ofloxacin-Based Chemotherapy in Multiply Drug-Resistant Pulmonary Tuberculosis

1993 • 11 citations